Refsum disease is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues. It is one of several disorders named after Norwegian neurologist Sigvald Bernhard Refsum (1907 to 1991). The disease typically begins to show symptoms during adolescence, although symptoms may first appear anywhere between infancy and old age, and it is definitively diagnosed by lab tests showing above average serum levels of phytanic acid or through genetic testing. Symptoms include ichthyosis, muscle weakness, anosmia, eye problems and cerebellar ataxia. It is caused primarily by mutations in the PHYH gene, which encodes phytanoyl-CoA hydroxylase, in about 90 percent of cases, or less commonly by mutations in the PEX7 gene. Treatment centers on a phytanic-acid-restricted diet and plasmapheresis. Its ICD-10 code is G60.1.
Facts
Classification
ICD-10 ChapterVI: Diseases of the Nervous System 1 Communicable or Non-communicable Transmission Route Causative Agent
Causative Agent (category) Sources
1. Refsum disease (Wikipedia)
Lead section, opening sentence
Refsum disease is an autosomal recessive neurological disease
Infobox, Genetic Basis field
primarily caused by mutations in the PHYH gene
Infobox, ICD-10 Code field
ICD-10 Code: G60.1
Infobox, Genetic Basis field [transmission-route]
Autosomal recessive inheritance
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.